Psychedelics Today, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

The Wild World of 19th Century Psychedelics

PTSF87 – Ketamine, Addiction, and Mysticism + Kelsey Ramsden of MINDCURE

Editor’s Choice Award 2021-Best Study on Psychedelics and Neurochemistry

Ibogaine and Cardiac Arrhythmia: The Heart of the Matter

Awakn Life Sciences Strengthens Executive Leadership Team

PharmaTher Granted New Japanese Patent for KETABET™ (Ketamine Combination Formulation), Strengthening...

Cybin Announces FDA Investigational New Drug and Institutional Review Board Approvals...

Wesana Health Reports Q3 2021 Financial Results

PT275 – James Fadiman, Ph.D. – Transpersonal Psychology, Microdosing, and Your...

Bright Minds Biosciences Provides Scientific Update on its Novel 5-HT2A Psychedelic...

1...176177178...218 Page 177 of 218

Pα+ Psychedelic Bulletin #196: Otsuka Eyes Psychedelic Future in Japan; First...

EXCLUSIVE: Heroic Hearts and Healing Breakthrough Merge to Expand Stateside Psychedelic...

Ibogaine – The Promise, the Protocol, and Protecting the Sacred

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin